## Abstract Diagnosis of erythrovirus B19 relies on serology and the detection of viral DNA. These techniques were believed to detect all field isolates because erythrovirus B19 has been known to undergo little genetic variation (1β2%). Recently, a distinct erythrovirus isolate termed V9, markedly
LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates
β Scribed by Gunnar Schalasta; Michael Schmid; Tessa Lachmund; Gisela Enders
- Book ID
- 102380285
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 96 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Until recently, B19 virus was considered to be the only human pathogen of the genus erythrovirus. However, other nonβB19 virus strains, such as V9, have now been isolated and are thought to cause infections clinically and serologically indistinguishable from those caused by B19 virus. Whereas B19 virus related isolates have a low genetic diversity of only 1β2%, nucleotide disparity of up to 12% was found for the new isolates, suggesting that nonβB19 virus isolates may not be detectable using B19 virus specific PCR methods. To overcome this problem, we designed consensus primers and probes to enable the simultaneous detection of both B19 and nonβB19 virus and subsequent discrimination of the two lineages by melting temperature (T~m~) analysis. A total of 196 clinical specimens, from 185 patients with a history of or an anamnesis resembling B19 virus infection, were analyzed using the consensus PCR test. Erythrovirus DNA was detected in 37 of these samples and was found to be B19 virus specific in each case, confirming previous results using B19 virus specific PCR. Although no nonβB19 virus DNA was detected in any of the clinical samples tested in this study, more extensive studies are warranted. The routine use of erythrovirus consensus PCR in the diagnosis of B19 virus infection should provide valuable information on the epidemiology and clinical role of nonβB19 virus isolates; its use in screening would increase the safety of blood products. J. Med. Virol. 73:54β59, 2004. Β© 2004 WileyβLiss, Inc.
π SIMILAR VOLUMES